These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

837 related items for PubMed ID: 15546209

  • 1. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
    Wen X, Jackson EF, Price RE, Kim EE, Wu Q, Wallace S, Charnsangavej C, Gelovani JG, Li C.
    Bioconjug Chem; 2004; 15(6):1408-15. PubMed ID: 15546209
    [Abstract] [Full Text] [Related]

  • 2. Cascade polymeric MRI contrast media derived from poly(ethylene glycol) cores: initial syntheses and characterizations.
    Fu Y, Raatschen HJ, Nitecki DE, Wendland MF, Novikov V, Fournier LS, Cyran C, Rogut V, Shames DM, Brasch RC.
    Biomacromolecules; 2007 May; 8(5):1519-29. PubMed ID: 17402781
    [Abstract] [Full Text] [Related]

  • 3. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents.
    Laus S, Ruloff R, Tóth E, Merbach AE.
    Chemistry; 2003 Aug 04; 9(15):3555-66. PubMed ID: 12898682
    [Abstract] [Full Text] [Related]

  • 4. PEG-g-poly(GdDTPA-co-L-cystine): a biodegradable macromolecular blood pool contrast agent for MR imaging.
    Mohs AM, Wang X, Goodrich KC, Zong Y, Parker DL, Lu ZR.
    Bioconjug Chem; 2004 Aug 04; 15(6):1424-30. PubMed ID: 15546211
    [Abstract] [Full Text] [Related]

  • 5. Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis, and properties.
    Ladd DL, Hollister R, Peng X, Wei D, Wu G, Delecki D, Snow RA, Toner JL, Kellar K, Eck J, Desai VC, Raymond G, Kinter LB, Desser TS, Rubin DL.
    Bioconjug Chem; 1999 Aug 04; 10(3):361-70. PubMed ID: 10346865
    [Abstract] [Full Text] [Related]

  • 6. Separation and characterization of the two diastereomers for [Gd(DTPA-bz-NH2)(H2O)]2-, a common synthon in macromolecular MRI contrast agents: their water exchange and isomerization kinetics.
    Burai L, Tóth E, Sour A, Merbach AE.
    Inorg Chem; 2005 May 16; 44(10):3561-8. PubMed ID: 15877439
    [Abstract] [Full Text] [Related]

  • 7. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P, Runge VM, Bücker A, Schürholz H, Reith W, Robert P, Jackson C, Lanz T, Schneider G.
    Invest Radiol; 2009 Apr 16; 44(4):200-6. PubMed ID: 19300099
    [Abstract] [Full Text] [Related]

  • 8. Lanthanide chelates of (bis)-hydroxymethyl-substituted DTTA with potential application as contrast agents in magnetic resonance imaging.
    Silvério S, Torres S, Martins AF, Martins JA, André JP, Helm L, Prata MI, Santos AC, Geraldes CF.
    Dalton Trans; 2009 Jun 28; (24):4656-70. PubMed ID: 19513474
    [Abstract] [Full Text] [Related]

  • 9. Polyaspartamide gadolinium complexes containing sulfadiazine groups as potential macromolecular MRI contrast agents.
    Yan GP, Liu ML, Li LY.
    Bioconjug Chem; 2005 Jun 28; 16(4):967-71. PubMed ID: 16029038
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and characterization of HE-24.8: a polymeric contrast agent for magnetic resonance angiography.
    Kiessling F, Heilmann M, Lammers T, Ulbrich K, Subr V, Peschke P, Waengler B, Mier W, Schrenk HH, Bock M, Schad L, Semmler W.
    Bioconjug Chem; 2006 Jun 28; 17(1):42-51. PubMed ID: 16417250
    [Abstract] [Full Text] [Related]

  • 11. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
    Yuan Z, Liu SY, Xiao XS, Zhong GR, Jiang QJ.
    Zhonghua Yi Xue Za Zhi; 2007 Mar 13; 87(10):673-8. PubMed ID: 17553304
    [Abstract] [Full Text] [Related]

  • 12. Development of a conjugated gadolinium and cisplatin-gelatin possessing properties as an intravascular contrast agent for MR imaging.
    Sonoda A, Nitta N, Ohta S, Seko A, Jo J, Morikawa S, Tabata Y, Takahashi M, Murata K.
    Eur J Radiol; 2009 Sep 13; 71(3):570-5. PubMed ID: 18502598
    [Abstract] [Full Text] [Related]

  • 13. A benzene-core trinuclear GdIII complex: towards the optimization of relaxivity for MRI contrast agent applications at high magnetic field.
    Livramento JB, Helm L, Sour A, O'Neil C, Merbach AE, Tóth E.
    Dalton Trans; 2008 Mar 07; (9):1195-202. PubMed ID: 18283380
    [Abstract] [Full Text] [Related]

  • 14. Comparison of a tartaric acid derived polymeric MRI contrast agent to a small molecule model chelate.
    Lucas RL, Benjamin M, Reineke TM.
    Bioconjug Chem; 2008 Jan 07; 19(1):24-7. PubMed ID: 18092744
    [Abstract] [Full Text] [Related]

  • 15. Effect of size and charge on pharmacokinetics and in vivo MRI contrast enhancement of biodegradable polydisulfide Gd(III) complexes.
    Zong Y, Guo J, Ke T, Mohs AM, Parker DL, Lu ZR.
    J Control Release; 2006 May 30; 112(3):350-6. PubMed ID: 16631270
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement.
    Ahrén M, Selegård L, Klasson A, Söderlind F, Abrikossova N, Skoglund C, Bengtsson T, Engström M, Käll PO, Uvdal K.
    Langmuir; 2010 Apr 20; 26(8):5753-62. PubMed ID: 20334417
    [Abstract] [Full Text] [Related]

  • 17. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
    Chen Z, Yu D, Liu C, Yang X, Zhang N, Ma C, Song J, Lu Z.
    J Drug Target; 2011 Sep 20; 19(8):657-65. PubMed ID: 21091273
    [Abstract] [Full Text] [Related]

  • 18. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization.
    Ogan MD, Schmiedl U, Moseley ME, Grodd W, Paajanen H, Brasch RC.
    Invest Radiol; 1987 Aug 20; 22(8):665-71. PubMed ID: 3667174
    [Abstract] [Full Text] [Related]

  • 19. Diethylenetriaminepentaacetic acid-gadolinium (DTPA-Gd)-conjugated polysuccinimide derivatives as magnetic resonance imaging contrast agents.
    Lee HY, Jee HW, Seo SM, Kwak BK, Khang G, Cho SH.
    Bioconjug Chem; 2006 Aug 20; 17(3):700-6. PubMed ID: 16704207
    [Abstract] [Full Text] [Related]

  • 20. Investigation using an HER-2/neu transgenic mouse model of a newly developed MR contrast agent with the effect of an antitumor drug.
    Sonoda A, Nitta N, Ohta S, Nitta-Seko A, Murata S, Jo J, Tabata Y, Takahashi M, Tani T, Murata K.
    J Magn Reson Imaging; 2009 Oct 20; 30(4):907-10. PubMed ID: 19787744
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.